Current controversies in bone marrow transplantation
著者
書誌事項
Current controversies in bone marrow transplantation
（Current clinical oncology）
Humana Press, c2000
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Leading transplant physicians critically review and interpret twenty-one key clinical challenges in bone marrow/hematopoietic cell transplantation, and offer their best personal recommendations for treatment. Topics range from transplant strategies to complications of bone marrow transplantation, including a discussion of the indications, benefits, and the risks for a variety of leukemias, lymphomas, and solid tumors. The authors debate such contentious issues as the appropriateness of transplants in older patients, how many stem cells are sufficient for engraftment, and the pros and cons of umbilical cord blood transplantation. Up-to-date and clinically focused, Current Controversies in Bone Marrow Transplantation offers clinical oncologists, hematology/oncology fellows in training, and residents in internal medicine today's best ready reference and management guide for all their critical oncologic problems arising from the use of bone marrow/stem cell transplantation.
目次
Part I. Transplant Strategies. How Many Stem Cells Are Sufficient for Engraftment?, Lynn C. O'Donnell, Patrick J. Elder and Belinda R. Avalos. Is Bone Marrow Transplantation Appropriate in Older Patients?, Brian J. Bolwell. What Is an Accurate Risk/Benefit Ratio for Umbilical Cord Cell Transplantation in Children and Adults?, Mary J. Laughlin. Are Busulfan-Based Preparative Regimens Equivalent, Worse, or Better than Total Body Irradiation Regimens?, Edward A. Copelan. Is Total Body Irradiation Necessary in Bone Marrow Transplantation for Pediatric ALL?, Susan R. Wiersma and Susan B. Shurin. Part II. Transplantation for Hematologic Malignancies. Stem Cell Transplantation for Chronic Myeloid Leukemia: Indications and Timing, Michael R. Bishop. Should All Adult Patients with Acute Lymphoblastic Leukemia in First Remission Undergo Allogeneic Bone Marrow Transplantation?, Sam L. Penza and Edward A. Copelan. What Is the Curative Potential of Refractory Leukemia with Related and Unrelated Allogeneic Transplants?, Matt E. Kalaycio. What Is the Role of Autologous Stem Cell Transplantation for Leukemia?, Selina M. Luger and Edward A. Stadtmauer. Autologous Transplantation for Hodgkin's Disease: Who Benefits?, Craig H. Moskowitz and Stephen D. Nimer. Hematopoietic Stem Cell Transplantation for Mantle Cell Lymphoma, Brad Pohlman. Is Autologous Transplantation for Non-Hodgkin's Lymphoma Underutilized?, Brian J. Bolwell. Part III. Transplantation for Solid Tumors. Do Patients Benefit from Autotransplants for Advanced Ovarian Cancer?, Janet Ruzich and Patrick J. Stiff. What Is the Optimal Timing of Autologous Transplantation for Metastatic Breast Cancer?, Stephanie F. Williams. Should All Patients with Inflammatory Breast Cancer Undergo Autologous Stem Cell Transplant?, Beth A. Overmoyer. High-Dose Chemotherapy with Stem Cell Rescue for Germ Cell Cancer?, E. Randolph Broun. Part IV. Complications of Transplantation. Graft-vs-Host Disease: Has Any Progress Been Made in the Past Decade?, Thomas R. Spitzer and Robert Sackstein. Veno-occlusive Disease of the Liver: Does Anything Really Work?, Scott I. Bearman. Myelodysplasia and Acute Leukemia Following High-Dose Chemotherapy, Dean S. McGaughey and James Vredenburgh. Can Aspergillus Infections Be Prevented in Allogeneic Bone Marrow Transplant Recipients?, Sherif B. Mossad and David L. Longworth. Prevention of Cytomegalovirus Infection After Allogeneic Bone Marrow Transplantation, Karim A. Adal and Robin K. Avery. Index.
「Nielsen BookData」 より
